The Canadian Atrial Fibrillation Anticoagulation Study was a randomized double-blind
placebo-controlled trial to assess the potential of warfarin to reduce systemic thromboembolism …

We performed a randomized, double-blind, placebo-controlled trial in 555 patients with
unstable angina who were hospitalized in coronary care units. Patients received one of four …

… Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive
ventricular premature depolarisations: CAMIAT—In this article by JA Cairns and colleagues …

Background During primary percutaneous coronary intervention (PCI), manual thrombectomy
may reduce distal embolization and thus improve microvascular perfusion. Small trials …

The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines program was
developed to aid clinicians in the management of these complex patients, as well as to …

Background In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous
coronary intervention (PCI) of the culprit lesion reduces the risk of cardiovascular death …

The Canadian Cardiovascular Society (CCS) published the complete set of 2010 Atrial
Fibrillation (AF) Guidelines in the January, 2011 issue of the Canadian Journal of Cardiology. …

Atrial fibrillation (AF) is an extremely common clinical problem with an important population
morbidity and mortality burden. The management of AF is complex and fraught with many …

Tryptase, a protease unique to the mast cell secretory granule, is released in substantial
quantities into the respiratory tract of patients with inflammatory disease of the airways. We have …

Mast cell activation is a characteristic feature of chronic inflammation, a condition that may
lead to fibrosis as a result of increased collagen synthesis by fibroblasts. We have …